Steffen Helmling
Corporate Officer/Principal chez eTheRNA immunotherapies NV
Profil
Steffen joined Novalis LifeSciences as a senior advisor in 2023.
He is currently the Chief Business Officer (CBO) of Etherna, a leading technology innovator for the creation of RNA-based medicines.
Prior to Etherna, Steffen served as CBO of X-Chem, a global small molecule drug discovery company.
Steffen holds a Ph.D.
in biochemistry from the School of Biomedical Sciences at Tufts University in Boston, Massachusetts.
Postes actifs de Steffen Helmling
| Sociétés | Poste | Début |
|---|---|---|
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Corporate Officer/Principal | 08/06/2023 |
Novalis Lifesciences LLC
 Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | Consultant / Advisor | 01/01/2023 |
Anciens postes connus de Steffen Helmling
| Sociétés | Poste | Fin |
|---|---|---|
| NOXXON Pharma, Inc. | Corporate Officer/Principal | - |
| POLYMEDIX, INC. | Corporate Officer/Principal | - |
Formation de Steffen Helmling
| Bowling Green State University | Graduate Degree |
| Tufts University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
| NOXXON Pharma, Inc. | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | Finance |
